The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,663 | -83,068 | 152 | -10,927 | -14,322 |
| Depreciation Amortization | 12,092 | 26,314 | 15,779 | 3,394 | 3,238 |
| Income taxes - deferred | 0 | -76 | -263 | -1,242 | -1,344 |
| Accounts receivable | -5,975 | -4,564 | -20,285 | -2,195 | -6,763 |
| Accounts payable and accrued liabilities | 9,215 | 5,057 | -6,187 | 2,916 | 3,758 |
| Other Working Capital | 18,059 | 2,359 | -20,541 | -14,489 | 992 |
| Other Operating Activity | 4,734 | 17,663 | -30,411 | -10,137 | 14,949 |
| Operating Cash Flow | $-26,538 | $-36,315 | $-61,756 | $-32,680 | $508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,789 | -4,567 | -5,529 | -2,847 | -1,194 |
| Net Acquisitions | N/A | -4,456 | -8,577 | -9,107 | -150 |
| Purchase Of Investment | 0 | -9,595 | -117,508 | 0 | N/A |
| Sale Of Investment | 50,000 | 81,258 | 0 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -200 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -200 | -7,500 |
| Investing Cash Flow | $46,211 | $62,640 | $-131,614 | $-12,154 | $-8,844 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 110,000 | N/A | 12,493 |
| Debt Repayment | -39 | -101 | -58 | -7,251 | -312 |
| Common Stock Issued | 75 | 126 | 858 | 0 | 50 |
| Common Stock Repurchased | 0 | -1,019 | -9,000 | 0 | N/A |
| Other Financing Activity | -3,528 | -5,853 | -9,594 | 161,261 | -343 |
| Financing Cash Flow | $-3,492 | $-6,847 | $92,206 | $154,010 | $11,888 |
| Beginning Cash Position | 33,488 | 14,010 | 115,174 | 5,998 | 2,446 |
| End Cash Position | 49,669 | 33,488 | 14,010 | 115,174 | 5,998 |
| Net Cash Flow | $16,181 | $19,478 | $-101,164 | $109,176 | $3,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,538 | -36,315 | -61,756 | -32,680 | 508 |
| Capital Expenditure | -3,789 | -4,567 | -5,529 | -2,847 | -1,194 |
| Free Cash Flow | -30,327 | -40,882 | -67,285 | -35,527 | -686 |